Skip to content

Kopra Bio

YC S24 · Active · Genetically engineered viruses that teach your immune system to kill…

Competitors

Adjacent

Also from S24

All of S24

About Kopra Bio

Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.

YC batch
S24 · Summer 2024
Status, per YC
Active
Category
Other
Team size
2
Location
San Francisco, CA, USA
Checked
35m ago

YC tags: Gene Therapy, Synthetic Biology, Biotech, Therapeutics, Oncology

Kopra Bio in S24: 248 companies, 85% AI

Kopra Bio: questions

Which YC batch was Kopra Bio in?

Kopra Bio was in Y Combinator's Summer 2024 batch (S24).

Is Kopra Bio still active?

Y Combinator lists Kopra Bio as active.

Where is Kopra Bio based?

Kopra Bio lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.